Allogeneic corneal tolerance in rodents with long-term graft survival

Transplantation

Volumn 79, Issue 10, 2005, Pages 1362-1369

  Yamada, Jun ^a,b   Hamuro, Junji ^b   Sano, Yoichiro ^b   Maruyama, Kazuichi ^b   Kinoshita, Shigeru ^b  

^a MEIJI UNIVERSITY OF INTEGRATIVE MEDICINE   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Corneal transplantation; Immunoregulation; Tolerance

Indexed keywords

ALLOANTIGEN;

ADOPTIVE TRANSFER; ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORNEA ENDOTHELIUM; CORNEA TRANSPLANTATION; DELAYED HYPERSENSITIVITY; ENDOTHELIUM CELL; GRAFT SURVIVAL; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; MALE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; RAT; SPLEEN CELL;

ADOPTIVE TRANSFER; ANIMALS; CORNEAL TRANSPLANTATION; GRAFT SURVIVAL; HYPERSENSITIVITY, DELAYED; LYMPHOCYTE CULTURE TEST, MIXED; LYMPHOCYTES; MALE; MICE; MICE, INBRED STRAINS; REOPERATION; T-LYMPHOCYTES; TIME FACTORS; TISSUE DONORS; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, HOMOLOGOUS;

EID: 19544375031     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000159869.55962.94     Document Type: Article

References (43)

1. Sonoda Y, Streilein JW. Impaired cell-mediated immunity in mice bearing healthy orthotopic corneal allografts. J Immunol 1993; 150: 1727.
2. Streilein JW, Bradley D, Sano Y, et al. Immunosuppressive properties of tissues obtained from eyes with experimentally manipulated corneas. Invest Ophthalmol Vis Sci 1996; 37: 413.
3. Niederkorn JY. Immune privilege and immune regulation in the eye. Adv Immunol 1990; 48: 191.
4. Streilein JW, Wilbanks GA, Cousins SW. Immunoregulatory mechanisms of the eye. J Neuroimmunol 1992; 39: 185.
5. Frangie JP, Leibowitz HM. Steroids Int Ophthalmol 1993; 33: 9.
6. Barraquer J. Immunosuppressive agents in penetrating keratoplasty. Am J Ophthalmol 1985; 100: 61.
7. Maumenee AE. The influence of donor-recipient sensitization on corneal grafts. Am J Ophthalmol 1951; 34: 142.
8. Sonoda Y, Streilein JW. Orthotopic corneal transplantation in mice-evidence that the immunogenetic rules of rejection do not apply. Transplantation 1992; 54: 694.
9. Sonoda Y, Ksander B, Streilein JW. Evidence that active suppression contributes to the success of H-2-incompatible orthotopic corneal allografts in mice. Transplant Proc 1993; 25: 1374.
10. Yamada J, Streilein JW. Induction of anterior chamber-associated immune deviation by corneal allografts placed in the anterior chamber. Invest Ophthalmol Vis Sci 1997; 38: 2833.
11. Hori J, Streilein JW. Dynamics of donor cell persistence and recipient cell replacement in orthotopic corneal allografts in mice. Invest Ophthalmol Vis Sci 2001; 42: 1820.
12. Sano Y, Ksander BR, Streilein JW. Fate of orthotopic corneal allografts in eyes that cannot support anterior chamber-associated immune deviation induction. Invest Ophthalmol Vis Sci 1995; 36: 2176.
13. Taylor AW, Streilein JW, Cousins SVV. Identification of alpha-melanocyte stimulating hormone as a potential immunosuppressive factor in aqueous humor. Curr Eye Res 1992; 11: 1199.
14. Dana MR, Yamada J, Streilein JW. Topical interleukin 1 receptor antagonist promotes corneal transplant survival. Transplantation 1997; 63: 1501.
15. Niederkorn JY. The immune privilege of corneal allografts. Transplantation 1999; 67: 1503.
16. Griffith TS, Brunner T, Fletcher SM, et al. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 1995; 270: 1189.
17. Streilein JW, Yamada J, Dana MR, et al. Anterior chamber-associated immune deviation, ocular immune privilege, and orthotopic corneal allografts. Transplant Proc 1999; 31: 1472.
18. Wilbanks GA, Streilein JW. Studies on the induction of anterior chamber-associated immune deviation (ACAID). 1. Evidence that an antigen-specific, ACAID-inducing, cell-associated signal exists in the peripheral blood. J Immunol 1991; 146: 2610.
19. Sonoda A, Sonoda Y, Muramatu R, et al. ACAID induced by allogeneic corneal tissue promotes subsequent survival of orthotopic corneal grafts. Invest Ophthalmol Vis Sci 2000; 41: 790.
20. Niederkorn JY. The immune privilege of corneal grafts. J Leukoc Biol 2003; 74: 167.
21. Sonoda KH, Taniguchi M, Stein-Streilein J. Long-term survival of corneal allografts is dependent on intact CD1d-reactive NKT cells. J Immunol 2002; 168: 2028.
22. Hegde S, Niederkorn JY. The role of cytotoxic T lymphocytes in corneal allograft rejection. Invest Ophthalmol Vis Sci 2000; 41: 3341.
23. Hori J, Streilein JW. Role of recipient epithelium in promoting survival of orthotopic corneal allografts in mice. Invest Ophthalmol Vis Sci 2001; 42: 720.
24. Skelsey ME, Mellon J, Niederkorn JY. Gamma delta T cells are needed for ocular immune privilege and corneal graft survival. J Immunol 2001; 166: 4327.
25. Hassan AT, Dai Z, Konieczny BT, et al. Regulation of alloantigen-mediated T-cell proliferation by endogenous interferon-gamma: implications for long-term allograft acceptance. Transplantation 1999; 68: 124.
26. Sano Y, Osawa H, Sotozono C, et al. Cytokine expression during orthotopic corneal allograft rejection in mice. Invest Ophthalmol Vis Sci 1998; 39: 1953.
27. Yamagami S, Kawashima H, Endo H, et al. Cytokine profiles of aqueous humor and graft in orthotopic mouse corneal transplantation. Transplantation 1998; 66: 1504.
28. Yamada J, Yoshida M, Taylor AW, et al. Mice with Th2-biased immune systems accept orthotopic corneal allografts placed in "high risk" eyes. J Immunol 1999; 162: 5247.
29. Qian Y, Boisgerault F, Benichou G, et al. Blockade of CD40-CD154 costimulatory pathway promotes survival of allogeneic corneal transplants. Invest Ophthalmol Vis Sci 2001; 42: 987.
30. Hargrave SL, Mellon J, Niederkorn J. MHC matching improves corneal allograft survival in mice with Th2-immune bias. Transplant Proc 2002; 34: 3413.
31. Yamagami S, Kawashima H, Tsuru T, et al. Role of Fas-Fas ligand interactions in the immunorejection of allogeneic mouse corneal transplants. Transplantation 1997; 64: 1107.
32. Stuart PM, Griffith TS, Usui N, et al. CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival. J Clin Invest 1997; 99: 396.
33. Shearer GM. HIV-induced immunopathogenesis. Immunity 1998; 9: 587.
34. Boisgerault F, Liu Y, Anosova N, et al. Role of CD4+ and CD8+ T cells in allorecognition: lessons from corneal transplantation. J Immunol 2001; 167: 1891.
35. Haskova Z, Usiu N, Pepose JS, et al. CD4+ T cells are critical for corneal, but not skin, allograft rejection. Transplantation 2000; 69: 483.
36. Murata Y, Amao M, Hamuro J. Sequential conversion of the redox status of macrophages dictates the pathological progression of autoimmune diabetes. Eur J Immunol 2003; 33: 1001.
37. Goerdt S, Orfanos CE. Other functions, other genes: alternative activation of antigen-presenting cells. Immunity 1999; 10: 137.
38. She SC, Steahly LP, Moticka EJ. Intracameral injection of allogeneic lymphocytes enhances corneal graft survival. Invest Ophthalmol Vis Sci 1990; 31: 1950.
39. Niederkorn JY, Mellon J. Anterior chamber-associated immune deviation promotes corneal allograft survival. Invest Ophthalmol Vis Sci 1996; 37: 2700.
40. Sano Y, Okamoto S, Streilein JW. Induction of donor-specific ACAID can prolong orthotopic corneal allograft survival in "high-risk" eyes. Curr Eye Res 1997; 16: 1171.
41. Sirak JH, Orosz CG, Roopenian DC, et al. Cardiac allograft tolerance: failure to develop in interleukin-4-deficient mice correlates with unusual allosensitization patterns. Transplantation 1998; 65: 1352.
42. Bickerstaff AA, Wang JJ, Pelletier RP, et al. Murine renal allografts: spontaneous acceptance is associated with regulated T cell-mediated immunity. J Immunol 2001; 167: 4821.
43. Sonoda Y, Sano Y, Ksander B, et al. Characterization of cell-mediated immune responses elicited by orthotopic corneal allografts in mice. Invest Ophthalmol Vis Sci 1995; 36: 427.